DIA524.69+0.22 0.04%
SPY751.83+2.66 0.36%
QQQ719.69+7.95 1.12%

Biosino unit Biosino Jinan wins China registration for ZS-2000 biochemical analyzer

PUBT·04/20/2026 14:33:35
Listen to the news
Biosino unit Biosino Jinan wins China registration for ZS-2000 biochemical analyzer
  • Biosino unit Biosino Medical Instrument Technology (Jinan) obtained PRC medical device registration for ZS-2000 fully automatic biochemical analyzer.
  • Certificate Lu Xie Zhu Zhun 20262220227 valid April 16, 2026 to April 15, 2031.
  • Registration clears product for legal launch, sales, and use in China.
  • ZS-2000 targets clinical biochemistry testing for hospitals and third-party labs, supporting Biosino instrument-reagent strategy.
  • Financial impact expected to be positive for current year results, subject to market and tendering risks.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biosino Bio-Technology and Science Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260420-12112904), on April 20, 2026, and is solely responsible for the information contained therein.

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.